Brief: OSE Immunotherapeutics Announces New Public Grant In Field Of RNA Therapeutics
Aug 1 (Reuters) - OSE Immunotherapeutics SA OSE.PA :
* ANNOUNCED THAT THE COMPANY HAS RECEIVED €200,000 GRANT
INNOVATION FUNDING FROM THE FRENCH GOVERNMENT AND REGION PAYS DE
LA LOIRE AS PART OF THE “FRANCE 2030 INVESTMENT PLAN” OPERATED
BY BPIFRANCE.
Source text for Eikon: ID:nBwlvQPda
Further company coverage: OSE.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Ose Immunotherapeutics SA
See all newsFactbox: Moderna-Merck melanoma vaccine leads race for first therapeutic cancer vaccine
Brief: OSE Immunotherapeutics SA Appoints Thomas Gidoin As Deputy CEO
Brief: Ose Immunotherapeutics Will Pause Development Of OSE‑230
Brief: OSE Immunotherapeutics Gets Second Positive IDMC Nod For Phase 3 Lung Cancer Trial
Brief: OSE Immunotherapeutics Announces Appointment Of Marc Le Bozec As Interim CEO